FDA OKs EarlySense monitoring device

11/20/2007 | Globes (Israel)

The FDA has granted Israel-based EarlySense Ltd. approval for its EverOn system, a heart and lung monitor that uses a proprietary contact-free sensor to reduce patient discomfort and enable monitoring at home and at hospitals. The system, which is being tested on patients with chronic diseases, is expected to be available next year.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY